There was a need to critically examine the safety and effectiveness of COVID-19 vaccine developed by Russia if it is successful, said All India Institutes of Medical Sciences (AIIMS) Delhi Director Dr Randeep Guleria on August 12.
“If Russia’s vaccine is successful, then we will have to see critically whether it is safe and effective. There should not be any side effects of the vaccine and it should provide good immunity and protection. India has the capacity for mass production of vaccine,” Dr. Guleria said assuring India’s capacity in mass production of the vaccine.
National Expert Group on Vaccine Administration formulated by the central government is scheduled to meet to discuss all matters concerned to logistics of vaccines, ways to address issues of equity etc., said Union Health Secretary Rajesh Bhushan.